February 24, 2021

Governors’ Group Questions Federal Pharmacy COVID-19 Program

It might just be a political squabble about control, but pharmacists have found themselves in the middle of a dispute between states and the federal government on COVID-19 vaccine distribution. Find out why some of the nation’s governors object to the roll out of a federal pharmacy program to get shots in the arms of as many Americans as possible.


Why SGTL2i Should Quickly Become Part of Heart Failure Therapy

Treatment with dapagliflozin, a sodium-glucose cotransporter 2 inhibitor (SGTL2i) inhibitor, made a significant difference for heart failure patients with reduced ejection fraction, and the effect was even more dramatic if they had recently been hospitalized, according to a new study. Find out why editors of a major journal are pushing for the therapy to become standard sooner rather than later. 

Asthma Control Reduced With More Sanitizing During COVID-19 Pandemic

Household cleaning protects often are respiratory irritants, and their increased use during the pandemic has lowered rates of asthma control, according to a new survey. The authors of the study recommend alternatives that asthma patients can use to sanitize without exacerbating their symptoms. Here are more details. 


COVID-19 and Metformin: What Diabetes Patients Need to Know

New research suggests that taking metformin has little effect on whether type 2 diabetes patients contract COVID-19 or have a severe—even deadly—case. The authors caution, however, that, while the common medication is generally safe, it is not without risk if patients become dehydrated during a bout with novel coronavirus. Here is what the authors recommend. 

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -